Defunct Company
Total Trials
6
As Lead Sponsor
5
As Collaborator
1
Total Enrollment
3,460
NCT01247428
First-In-Human Trial of the MiStent Drug-Eluting Stent (DES) in Coronary Artery Disease
Phase: Phase 2
Role: Lead Sponsor
Start: Nov 30, 2010
Completion: Mar 31, 2016
NCT01294748
Clinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery Disease
Start: Feb 28, 2011
Completion: Aug 31, 2016
NCT02385279
Study Comparing the MiStent SES Versus the XIENCE EES Stent
Phase: N/A
Role: Collaborator
Start: Mar 20, 2015
Completion: Feb 4, 2021
NCT02448524
Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System)
Phase: Phase 3
Start: Jul 31, 2015
Completion: Nov 30, 2022
NCT02972671
Trial of MiStent Compared to Xience in Japan
Start: Nov 28, 2016
Completion: Apr 30, 2022
NCT03423511
Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries.
Start: Dec 31, 2021
Completion: Jun 1, 2027